STOCK TITAN

Ipsen: Disclosure Transaction in Own Shares Between 22/08/2022 To 26/08/2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

PARIS--(BUSINESS WIRE)-- Regulatory News:

Aggregated presentation by day and market

Issuer name

Issuer identification code

Transaction date

Identification code of the
financial instrument

Daily total volume (in
number of shares)

Daily weighted
average price of
shares acquired

Platform

IPSEN

549300M6SGDPB4Z94P11

22/08/2022

FR0010259150

3 000

97,1242

XPAR

IPSEN

549300M6SGDPB4Z94P11

23/08/2022

FR0010259150

2 500

95,8669

XPAR

IPSEN

549300M6SGDPB4Z94P11

24/08/2022

FR0010259150

2 000

95,2553

XPAR

IPSEN

549300M6SGDPB4Z94P11

26/08/2022

FR0010259150

3 000

97,8671

XPAR

 

 

 

TOTAL

10 500

96,6811

 

 

Craig Marks

Vice-President Investor Relations

Tel.: +44 (0) 7584 349 193

E-mail: craig.marks@ipsen.com

Anne Piot

Vice President Corporate Governance & Chief Risk Officer

Tel.: +33 (0)1 58 33 58 86

E-mail: anne.piot.dabzac@ipsen.com

Source: Ipsen

Ipsen S.A.

OTC:IPSEY

IPSEY Rankings

IPSEY Latest News

IPSEY Stock Data

9.72B
30.55M
0.01%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
Boulogne Billancourt